Fundraising FoxAptatargets
Madrid, ES · 2 known investors
Find your way into Aptatargets
Sign up to see every warm intro you have to Aptatargets
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Aptatargets team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
aptaTargets develops aptamer-based therapeutics and diagnostics for cerebrovascular diseases, with a lead program (ApTOLL) targeting stroke treatment. The company applies aptamer technology platforms to clinical applications in neurology.
Founders & leadership
D
DavidCo-Founder & CEO
ME
Maria EugeniaCo-Founder & CFOMaria Eugenia is co-founder and CFO of aptaTargets, where she leads finance, corporate development, and strategic guidance for the aptamer-based therapeutics company. She has nearly two decades of experience in life sciences entrepreneurship, has directed over €20 million in public and private funding rounds, and is a co-inventor on multiple international patents related to the company's therapeutic programs.
Investors · 2
Frequently asked questions
- What does Aptatargets do?
- aptaTargets develops aptamer-based therapeutics and diagnostics for cerebrovascular diseases, with a lead program (ApTOLL) targeting stroke treatment. The company applies aptamer technology platforms to clinical applications in neurology.
- Who founded Aptatargets?
- Aptatargets was founded by David, Maria Eugenia.
- Who are Aptatargets's investors?
- Aptatargets's investors include Criteria Bio Ventures, Inveready Technology Investment Group.
- Where is Aptatargets headquartered?
- Aptatargets is headquartered in Madrid, ES.